{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:51:45Z","timestamp":1791229905243,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.cca.2020.11.023","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T20:50:37Z","timestamp":1606942237000},"page":"66-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["BRCA1 and BRCA2 truncating mutations and variants of unknown significance in Egyptian female breast cancer patients"],"prefix":"10.1016","volume":"512","author":[{"given":"Sherihan G.","family":"AbdelHamid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel-Rahman N.","family":"Zekri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hany M.","family":"AbdelAziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala O.","family":"El-Mesallamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2018","key":"10.1016\/j.cca.2020.11.023_b0005","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics, GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA-Cancer J. Clin."},{"key":"10.1016\/j.cca.2020.11.023_b0010","series-title":"Cancer of the Breast","first-page":"c2002","article-title":"History of breast cancer","author":"Donegan","year":"2002"},{"key":"10.1016\/j.cca.2020.11.023_b0015","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ajhg.2015.04.019","article-title":"Tracing the route of modern humans out of Africa by using 225 human genome sequences from Ethiopians and Egyptians","volume":"96","author":"Pagani","year":"2015","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cca.2020.11.023_b0020","doi-asserted-by":"crossref","first-page":"e0167581","DOI":"10.1371\/journal.pone.0167581","article-title":"Unique features of germline variation in five Egyptian familial breast cancer families revealed by exome sequencing","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cca.2020.11.023_b0025","article-title":"Cancer incidence in Egypt: results of the national population-based cancer registry program","volume":"18","author":"Ibrahim","year":"2014","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.cca.2020.11.023_b0030","first-page":"99","article-title":"Assessment of factors that hinder early detection of breast cancer among females at Cairo University Hospital","volume":"23","author":"Ismail","year":"2013","journal-title":"World Appl. Sci. J."},{"key":"10.1016\/j.cca.2020.11.023_b0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1472-6874-11-44","article-title":"Molecular subtype analysis determines the association of advanced breast cancer in Egypt with favorable biology","volume":"11","author":"Salhia","year":"2011","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.cca.2020.11.023_b0040","article-title":"Trends in breast cancer incidence rates by age and stage at diagnosis in Gharbiah, Egypt, over 10 Years (1999\u20132008)","volume":"7","author":"Hirko","year":"2013","journal-title":"J. Cancer Epidemiol."},{"key":"10.1016\/j.cca.2020.11.023_b0045","doi-asserted-by":"crossref","first-page":"381574","DOI":"10.1155\/2015\/381574","article-title":"Breast cancer by age at diagnosis in the Gharbiah, Egypt, population-based registry compared to the United States Surveillance, Epidemiology, and End Results Program, 2004\u20132008","volume":"2015","author":"Schlichting","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.cca.2020.11.023_b0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev-genom-083118-014954","article-title":"Consanguinity and inbreeding in health and disease in North African populations","volume":"20","author":"Romdhane","year":"2019","journal-title":"Annu. Rev. Genom. Hum. G"},{"key":"10.1016\/j.cca.2020.11.023_b0055","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Sci."},{"key":"10.1016\/j.cca.2020.11.023_b0060","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","article-title":"Identification of the breast cancer susceptibility gene BRCA2","volume":"378","author":"Wooster","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.cca.2020.11.023_b0065","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10689-017-0038-2","article-title":"Mutations in context: implications of BRCA testing in diverse populations","volume":"17","author":"Felix","year":"2018","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.cca.2020.11.023_b0070","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3390\/cancers10120487","article-title":"Role of BRCA mutations in cancer treatment with poly(ADP-ribose) polymerase (PARP) inhibitors","volume":"10","author":"Faraoni","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cca.2020.11.023_b0075","first-page":"11:265","article-title":"A high-throughput protocol for mutation scanning of the BRCA1 and BRCA2 genes","volume":"24","author":"Hondow","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cca.2020.11.023_b0080","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10689-015-9858-0","article-title":"Screening of the BRCA1 gene in Brazilian patients with breast and\/or ovarian cancer via high-resolution melting reaction analysis","volume":"15","author":"de Oliveira","year":"2016","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.cca.2020.11.023_b0085","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1756-9966-29-82","article-title":"Pre-symptomatic breast cancer in Egypt: role of BRCA1 and BRCA2 tumor suppressor genes mutations detection","volume":"29","author":"Ibrahim","year":"2010","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cca.2020.11.023_b0090","first-page":"9","article-title":"Detection of BRCA1 and BRCA2 gene mutation in Egyptian females with breast cancer and their relatives by PCR-SSCP method","volume":"18","author":"Fattouh","year":"2011","journal-title":"Egypt. J. Immunol."},{"key":"10.1016\/j.cca.2020.11.023_b0095","first-page":"82","article-title":"Breast cancer gene 1 (Brca 1) mutation in female patients with or without family history in Qalubia Governorate","volume":"7","author":"El-Debaky","year":"2011","journal-title":"Am. J. Sci."},{"key":"10.1016\/j.cca.2020.11.023_b0100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4172\/2572-4118.1000117","article-title":"Detection of BRCA1 founder mutation 185DELAG in breast cancer patients using pyrosequencing technique","volume":"2","author":"Saied","year":"2017","journal-title":"Breast Can Curr Res."},{"key":"10.1016\/j.cca.2020.11.023_b0105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/(SICI)1520-6866(1997)17:3<115::AID-TCM3>3.0.CO;2-K","article-title":"Effects in the comet assay of storage conditions on human blood","volume":"17","author":"Anderson","year":"1997","journal-title":"Teratog Carcinog Mutagen"},{"key":"10.1016\/j.cca.2020.11.023_b0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N","article-title":"Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion","volume":"15","author":"Dunnen","year":"2000","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.cca.2020.11.023_b0115","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/jmg.2005.033878","article-title":"A comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral","volume":"43","author":"Tavtigian","year":"2006","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.cca.2020.11.023_b0120","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1093\/nar\/gkf493","article-title":"Human non-synonymous SNPs: server and survey","volume":"30","author":"Ramensky","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cca.2020.11.023_b0125","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1093\/nar\/gkg509","article-title":"SIFT: Predicting amino acid changes that affect protein function","volume":"31","author":"Ng","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cca.2020.11.023_b0130","doi-asserted-by":"crossref","first-page":"W222","DOI":"10.1093\/nar\/gkx313","article-title":"PMut: a web-based tool for the annotation of pathological variants on proteins, 2017 update","volume":"45","author":"L\u00f3pez-Ferrando","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cca.2020.11.023_b0135","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.cca.2020.11.023_b0140","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12885-019-5463-1","article-title":"Prevalence of BRCA mutations among hereditary breast and\/or ovarian cancer patients in Arab countries: systematic review and meta-analysis","volume":"21","author":"Abdulrashid","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cca.2020.11.023_b0145","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.ygyno.2012.03.007","article-title":"BRCA1and BRCA2 germline mutations in Moroccan breast\/ovarian cancer families: Novel mutations and unclassified variants","volume":"25","author":"Tazzite","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cca.2020.11.023_b0150","doi-asserted-by":"crossref","first-page":"E36","DOI":"10.1684\/bdc.2014.2049","article-title":"Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and\/or ovarian cancer","volume":"101","author":"Fourati","year":"2014","journal-title":"Bull. Cancer"},{"key":"10.1016\/j.cca.2020.11.023_b0155","first-page":"7869095","article-title":"Contribution of BRCA1 and BRCA2 germline mutations to early Algerian breast cancer","author":"Henouda","year":"2016","journal-title":"Dis. Markers"},{"key":"10.1016\/j.cca.2020.11.023_b0160","doi-asserted-by":"crossref","first-page":"60","DOI":"10.7150\/ijms.5014","article-title":"Mutation screening of the BRCA1 gene in early onset and familial breast\/ovarian cancer in Moroccan population","volume":"10","author":"Laraqui","year":"2013","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.cca.2020.11.023_b0165","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1155\/2010\/585278","article-title":"BRCA1 and BRCA2 germline mutations screening in Algerian breast\/ovarian cancer families","volume":"28","author":"Cherbal","year":"2010","journal-title":"Dis. Markers"},{"key":"10.1016\/j.cca.2020.11.023_b0170","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0959-8049(00)00045-9","article-title":"Significantly lower rates of BRCA1\/BRCA2 founder mutations in Ashkenazi women with sporadic compared with familial early onset breast cancer","volume":"36","author":"Gershoni-Baruch","year":"2000","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.cca.2020.11.023_b0175","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3389\/fonc.2018.00323","article-title":"BRCA1 and BRCA2 mutations other than the founder alleles among Ashkenazi Jewish in the population of Argentina","volume":"8","author":"Solano","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cca.2020.11.023_b0180","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/annonc\/mdh352","article-title":"BRCA1 and BRCA2 mutations as prognostic factors in bilateral breast cancer patients","volume":"15","author":"Rogozi\u0144ska-Szczepka","year":"2004","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.cca.2020.11.023_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biocel.2015.12.008","article-title":"New concepts on BARD1: Regulator of BRCA pathways and beyond","volume":"72","author":"Irminger-Finger","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.cca.2020.11.023_b0190","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.2002.20.6.1480","article-title":"Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals","volume":"15","author":"Frank","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cca.2020.11.023_b0195","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1200\/JCO.2004.04.179","article-title":"Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients","volume":"1","author":"Choi","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cca.2020.11.023_b0200","first-page":"701","article-title":"Classification of variants of uncertain significance in BRCA1 and BRCA2 using personal and family history of cancer from individuals in a large hereditary cancer multigene panel testing cohort","volume":"2","author":"Li","year":"2019","journal-title":"Genet. Med."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120305568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120305568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:55:32Z","timestamp":1757861732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898120305568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":40,"alternative-id":["S0009898120305568"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2020.11.023","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BRCA1 and BRCA2 truncating mutations and variants of unknown significance in Egyptian female breast cancer patients","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2020.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}